Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.4K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.4K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.9K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Master Transcription Regulators02:23

Master Transcription Regulators

7.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.8K
Master Transcription Regulators02:23

Master Transcription Regulators

2.8K
2.8K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

404
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
404

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endogenous neoantigen-specific antibodies mediate antitumor responses and determine vaccine efficacy.

Journal for immunotherapy of cancer·2026
Same author

Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid Tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

Cancer research communications·2026
Same author

Childhood Cancer Data Initiative Participant Index: Mapping Pediatric Cancer Data to Facilitate Cross-Study Integrated Analysis.

JCO clinical cancer informatics·2026
Same author

The Randomized Phase II ARC-9 Study of Etrumadenant-Based Therapy versus Regorafenib in Patients with Previously Treated Metastatic Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Targeted therapy for DNA damage response and homologous recombination repair defects: The Olaparib Combinations trial.

Cancer·2026

Related Experiment Video

Updated: Jan 30, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Challenges with Novel Clinical Trial Designs: Master Protocols.

Michael Cecchini1, Eric H Rubin2, Gideon M Blumenthal3

  • 1Yale Cancer Center, New Haven, Connecticut. michael.cecchini@yale.edu.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 31, 2019
PubMed
Summary

Novel clinical trial designs like master protocols (umbrella, platform, basket trials) accelerate drug development but present unique challenges for all stakeholders. Addressing these complexities is key to improving anticancer agent evaluation.

More Related Videos

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K

Related Experiment Videos

Last Updated: Jan 30, 2026

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
11:27

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System

Published on: April 25, 2012

15.9K
Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K

Area of Science:

  • Oncology
  • Clinical Trial Design
  • Drug Development

Background:

  • The 2018 Accelerating Anticancer Agent Development (AAADV) Workshop convened experts to discuss challenges in novel clinical trial designs.
  • Master protocols, including umbrella, platform, and basket trials, are innovative approaches to expedite drug assessment.

Discussion:

  • Umbrella and platform trials typically evaluate multiple agents across different arms for patients with similar histology.
  • Basket trials enroll patients with diverse tumor types based on specific mutations or biomarkers, potentially including expansion cohorts.
  • These advanced designs aim for faster drug evaluation and approval but introduce complexities for industry, FDA, investigators, IRBs, and patients.

Key Insights:

  • Master protocols offer a promising pathway for efficient anticancer drug development.
  • Identifying and understanding the specific challenges posed by these complex trial designs is crucial.
  • Collaboration among all stakeholders is essential to navigate the hurdles of novel trial methodologies.

Outlook:

  • Developing strategies to address the identified challenges is paramount for successful implementation of master protocols.
  • Continued expert dialogue and refinement of trial designs will facilitate the integration of these innovative approaches.
  • The future of oncology drug development hinges on overcoming the complexities of novel clinical trial designs.